摘要：
2026年3月3日, 北京大学药学院天然药物及仿生药物全国重点实验室汪贻广教授、张强院士、陈斌龙副研究员团队在国际著名学术期刊Nature Materials上发表了题为“In situ-generated vaccine-like pyroptosome for personalized cancer immunotherapy”的研究工作。
Supporting:
北京大学药学院天然药物及仿生药物全国重点实验室. 汪贻广/张强/陈斌龙团队开发基于焦亡的个性化癌症免疫治疗新策略[J]. 中国药学(英文版), 2026, 35(5): 505-505.
State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University Health Science Center. The research teams of Prof. Yiguang Wang/Prof. Qiang Zhang/Prof. Binlong Chen have developed a new personalized cancer immunotherapy strategy based on pyroptosis[J]. Journal of Chinese Pharmaceutical Sciences, 2026, 35(5): 505-505.
>
>